BIOMAT Database Logo BIOMAT Database Logo

Suppression of HIV replication in vitro by CD8+ T-cells from HIV-infected and HIV-seronegative individuals. 1997

H Tsuchie, and M A Detorio, and M M Hossain, and N Tesfamariam, and A Trickett, and P R Lam-Po-Tang, and O Yamada, and H Ichimura, and J M Dwyer, and T Kurimura
Research Institute for Microbial Diseases, Osaka University, Suita, Japan.

The inhibitory effect of CD8+ T-cells from HIV-infected or HIV-seronegative individuals on HIV replication in the naturally-infected CD4+ T-cells in vitro was examined. Not only autologous CD8+ T-cells from HIV-infected individuals but also allogeneic CD8+ T-cells from HIV-seronegative individuals prevented or delayed HIV replication, even in transwell cocultures using a semi-permeable 0.45 micron filter. The level of the inhibitory effect of allogeneic CD8+ T-cells from the HIV-seronegative individuals on the HIV replication was varied among CD4+ T-cells obtained from HIV-infected individuals used. The results suggested that CD8+ T-cells from HIV-seronegative individuals as well as HIV-infected individuals could produce some cytokine(s) which suppress HIV replication in vitro. The sensitivity to the cytokine(s) might be variable among HIV strains, depending on differences in the nucleotide sequence of different HIV-1 strains. Further studies of control of HIV replication by CD8+ anti-HIV cytokine(s) should provide new strategies for the therapy of HIV infection.

UI MeSH Term Description Entries
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016655 HIV Core Protein p24 A major core protein of the human immunodeficiency virus encoded by the HIV gag gene. HIV-seropositive individuals mount a significant immune response to p24 and thus detection of antibodies to p24 is one basis for determining HIV infection by ELISA and Western blot assays. The protein is also being investigated as a potential HIV immunogen in vaccines. HIV Major Core Protein p24,HIV gag Gene Product p24,HIV p24 Antigen,gag Protein p24, HIV,p24(HIV),HIV Protein p24,HTLV-III p24,p24 protein, Human Immunodeficiency Virus,HTLV III p24,p24 Antigen, HIV,p24, HIV Protein,p24, HTLV-III
D018023 HIV Seronegativity Immune status consisting of non-production of HIV antibodies, as determined by various serological tests. HTLV-III Seronegativity,HIV Seronegativities,HTLV III Seronegativity,HTLV-III Seronegativities,Seronegativities, HIV,Seronegativities, HTLV-III,Seronegativity, HIV,Seronegativity, HTLV-III
D018414 CD8-Positive T-Lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes. Suppressor T-Lymphocytes, CD8-Positive,T8 Cells,T8 Lymphocytes,CD8-Positive Lymphocytes,Suppressor T-Cells, CD8-Positive,CD8 Positive Lymphocytes,CD8 Positive T Lymphocytes,CD8-Positive Lymphocyte,CD8-Positive Suppressor T-Cell,CD8-Positive Suppressor T-Cells,CD8-Positive Suppressor T-Lymphocyte,CD8-Positive Suppressor T-Lymphocytes,CD8-Positive T-Lymphocyte,Cell, T8,Cells, T8,Lymphocyte, CD8-Positive,Lymphocyte, T8,Lymphocytes, CD8-Positive,Lymphocytes, T8,Suppressor T Cells, CD8 Positive,Suppressor T Lymphocytes, CD8 Positive,Suppressor T-Cell, CD8-Positive,Suppressor T-Lymphocyte, CD8-Positive,T-Cell, CD8-Positive Suppressor,T-Cells, CD8-Positive Suppressor,T-Lymphocyte, CD8-Positive,T-Lymphocyte, CD8-Positive Suppressor,T-Lymphocytes, CD8-Positive,T-Lymphocytes, CD8-Positive Suppressor,T8 Cell,T8 Lymphocyte

Related Publications

H Tsuchie, and M A Detorio, and M M Hossain, and N Tesfamariam, and A Trickett, and P R Lam-Po-Tang, and O Yamada, and H Ichimura, and J M Dwyer, and T Kurimura
CD8+ T cells from HIV type 1-seronegative individuals suppress virus replication in acutely infected cells.
January 1997, AIDS research and human retroviruses,
H Tsuchie, and M A Detorio, and M M Hossain, and N Tesfamariam, and A Trickett, and P R Lam-Po-Tang, and O Yamada, and H Ichimura, and J M Dwyer, and T Kurimura
Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals.
December 1994, Cellular immunology,
H Tsuchie, and M A Detorio, and M M Hossain, and N Tesfamariam, and A Trickett, and P R Lam-Po-Tang, and O Yamada, and H Ichimura, and J M Dwyer, and T Kurimura
Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals.
November 1996, Proceedings of the National Academy of Sciences of the United States of America,
H Tsuchie, and M A Detorio, and M M Hossain, and N Tesfamariam, and A Trickett, and P R Lam-Po-Tang, and O Yamada, and H Ichimura, and J M Dwyer, and T Kurimura
Suppression of HIV-1 replication by HIV-1-irrelevant CD8+ cytotoxic T lymphocytes resulting in preservation of persistently HIV-1-infected cells in vitro.
January 2003, Viral immunology,
H Tsuchie, and M A Detorio, and M M Hossain, and N Tesfamariam, and A Trickett, and P R Lam-Po-Tang, and O Yamada, and H Ichimura, and J M Dwyer, and T Kurimura
Suppression of HIV Replication by CD8(+) Regulatory T-Cells in Elite Controllers.
January 2016, Frontiers in immunology,
H Tsuchie, and M A Detorio, and M M Hossain, and N Tesfamariam, and A Trickett, and P R Lam-Po-Tang, and O Yamada, and H Ichimura, and J M Dwyer, and T Kurimura
CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals.
April 1989, Cellular immunology,
H Tsuchie, and M A Detorio, and M M Hossain, and N Tesfamariam, and A Trickett, and P R Lam-Po-Tang, and O Yamada, and H Ichimura, and J M Dwyer, and T Kurimura
HIV-1 protective epitope-specific CD8+ T cells in HIV-1-exposed seronegative individuals.
November 2023, iScience,
H Tsuchie, and M A Detorio, and M M Hossain, and N Tesfamariam, and A Trickett, and P R Lam-Po-Tang, and O Yamada, and H Ichimura, and J M Dwyer, and T Kurimura
Differential gene expression in CD8(+) cells from HIV-1-infected subjects showing suppression of HIV replication.
May 2007, Virology,
H Tsuchie, and M A Detorio, and M M Hossain, and N Tesfamariam, and A Trickett, and P R Lam-Po-Tang, and O Yamada, and H Ichimura, and J M Dwyer, and T Kurimura
In vitro HIV-primed cytotoxic T-lymphocytes from seronegative individuals.
September 1992, AIDS (London, England),
H Tsuchie, and M A Detorio, and M M Hossain, and N Tesfamariam, and A Trickett, and P R Lam-Po-Tang, and O Yamada, and H Ichimura, and J M Dwyer, and T Kurimura
Inverted CD8 T-Cell Exhaustion and Co-Stimulation Marker Balance Differentiate Aviremic HIV-2-Infected From Seronegative Individuals.
January 2021, Frontiers in immunology,
Copied contents to your clipboard!